These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1727122)

  • 41. Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.
    Romano KD; Pugh KJ; Trifiletti DM; Libby B; Showalter TN
    Brachytherapy; 2017; 16(2):378-386. PubMed ID: 28139420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator.
    Bahena JH; Martinez A; Yan D; Mele E; Edmunson G; Brown D; Hardy M; Brabbins D; Gustafson G
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):13-9. PubMed ID: 9588912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brachytherapy for carcinoma of the cervix: a Canadian survey of practice patterns in a changing era.
    Pearce A; Craighead P; Kay I; Traptow L; Doll C
    Radiother Oncol; 2009 May; 91(2):194-6. PubMed ID: 18922592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic Resonance Imaging-Guided High-Dose Rate Brachytherapy for Cervical Cancer.
    Meier T; Kharofa J
    Semin Roentgenol; 2016 Apr; 51(2):106-11. PubMed ID: 27105965
    [No Abstract]   [Full Text] [Related]  

  • 45. High-dose-rate brachytherapy for carcinoma of the cervix: high tech or high risk?
    Eifel PJ
    Int J Radiat Oncol Biol Phys; 1992; 24(2):383-6; discussion 387-8. PubMed ID: 1526879
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiation therapy of cervical carcinoma using either HDR or LDR afterloading: comparison of 5-year results and complications.
    Cikarić S
    Sonderb Strahlenther Onkol; 1988; 82():119-22. PubMed ID: 3134706
    [No Abstract]   [Full Text] [Related]  

  • 48. Image-guided brachytherapy for cervix cancer: from Manchester to Melbourne.
    Narayan K; Barkati M; van Dyk S; Bernshaw D
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):41-6. PubMed ID: 20014884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Simplified HDR-afterloading and high-voltage therapy of cervical carcinoma].
    Hetzel H; Fritsch E; Url M; Frommhold H; Dapunt O
    Strahlenther Onkol; 1987 Dec; 163(12):774-81. PubMed ID: 3122347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-year results of HDR afterloading in comparison with radium therapy in Sarajevo.
    Djordjević J; Bilenjki D; Strinic S
    Sonderb Strahlenther Onkol; 1988; 82():156-9. PubMed ID: 3134711
    [No Abstract]   [Full Text] [Related]  

  • 51. [The value of NMR tomography in the planning of HDR-afterloading brachytherapy in cervical carcinomas. The experiences with 41 patients].
    Schmidt BF; Hirnle P; Kaulich TW; Skalej M; Bamberg M
    Rofo; 1991 Aug; 155(2):109-16. PubMed ID: 1878536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiation Oncology Management of Stage I-III Cervix Cancer.
    de Souza Lawrence L
    Surg Oncol Clin N Am; 2017 Jul; 26(3):477-489. PubMed ID: 28576184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HDR brachytherapy makes Cs-137 intracavitary therapy for cervix cancer a breach of good practice.
    Gillin MT; Palta JR
    Med Phys; 1999 Apr; 26(4):499-501. PubMed ID: 10227349
    [No Abstract]   [Full Text] [Related]  

  • 54. High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix.
    Fu KK; Phillips TL
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):791-6. PubMed ID: 2145249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results of a questionnaire regarding the practice of radiotherapy for carcinoma of the cervix in the UK.
    Jones B; Tan LT; Blake PR; Dale RG
    Br J Radiol; 1994 Dec; 67(804):1226-30. PubMed ID: 7874422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
    Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intra-fraction uncertainties of MRI guided brachytherapy in patients with cervical cancer.
    Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Westerveld H; Jürgenliemk-Schulz IM
    Radiother Oncol; 2014 Aug; 112(2):217-20. PubMed ID: 25216574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
    Sha RL; Reddy PY; Rao R; Muralidhar KR; Kudchadker RJ
    Med Dosim; 2011; 36(4):377-82. PubMed ID: 21144733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical significance of the shape of isodose curves in intracavitary radiation therapy of carcinoma of the uterine cervix].
    Higuchi T
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2251-62. PubMed ID: 3831171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.